Robert B. Jones
Net Worth

Last updated:

What is Robert B. Jones net worth?

The estimated net worth of Mr. Robert B. Jones is at least $2,120,628 as of 20 Nov 2023. He owns shares worth $20,628 as insider and has received compensation worth at least $2,100,000 in Acura Pharmaceuticals, Inc..

What is the salary of Robert B. Jones?

Mr. Robert B. Jones salary is $150,000 per year as Chief Executive Officer, Pres & Director in Acura Pharmaceuticals, Inc..

How old is Robert B. Jones?

Mr. Robert B. Jones is 66 years old, born in 1959.

What stocks does Robert B. Jones currently own?

As insider, Mr. Robert B. Jones owns shares in one company:

Company Title Shares Price per share Total value
Acura Pharmaceuticals, Inc. (ACUR) Chief Executive Officer, Pres & Director 412,555 $0.05 $20,628

What does Acura Pharmaceuticals, Inc. do?

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.

ACUR logo
ACUR
Acura Pharmaceuticals, Inc.
$0.05

Robert B. Jones insider trading

Acura Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 40,000 $0.01 $400
Option
Restricted Stock Unit (2021 Plan) 40,000 $0.01 $400
Option
Restricted Stock Unit (2017 Plan) 50,000 N/A N/A
Option
Common Stock 50,000 N/A N/A
Option
Restricted Stock Unit (2017 Plan) 13,666 $0.01 $137
Option
Restricted Stock Unit (2017 Plan) 50,000 $0.01 $500
Option
Common Stock 63,666 N/A N/A
Option
Common Stock 63,667 N/A N/A
Option
Restricted Stock Unit (2017 Plan) 50,000 N/A N/A
Option
Restricted Stock Unit (2017 Plan) 13,667 $0.01 $137
Option
Restricted Stock Unit (2017 Plan) 13,667 $0.01 $137
Option
Common Stock 13,667 $0.01 $137
Purchase
Common Stock 400,000 $0.1 $40,000
Purchase
Commmon Stock 1,000 $3.24 $3,240
Purchase
Common Stock 400 $3.23 $1,292
Purchase
Common Stock 300 $3.22 $966
Purchase
Common Stock 1,300 $3.24 $4,206

Acura Pharmaceuticals key executives

Acura Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Albert W. Brzeczko (68) Vice President of Pharmaceutical Sciences of Acura Pharmaceutical Technologies, Inc.
  • Mr. Peter A. Clemens (72) Senior Vice President, Chief Financial Officer & Sec.
  • Mr. Robert B. Jones (66) Chief Executive Officer, Pres & Director